CYTORI LIPOPLASTY SYSTEM WITH CELASE REAGENT— 510(k) K063235
Substantially EquivalentCytori Therapeutics, Inc.
FDA 510(k) clearance K063235 for CYTORI LIPOPLASTY SYSTEM WITH CELASE REAGENT, Substantially Equivalent on 2007-01-24. Applicant: Cytori Therapeutics, Inc.. Device class: 2.
Clearance details
- Applicant
- Cytori Therapeutics, Inc.
- Product code
- Code QPB
- Device class
- Class 2
- Regulation
- 21 CFR 878.5040
- Advisory panel
- General, Plastic Surgery
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- San Diego, CA, US
Recent devices under product code QPB
view allMore clearances from Cytori Therapeutics, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.